Krishnam Raju Narsepalle highlights the evolution of enterprise data systems, focusing on reliability, auditability, and long ...

As part of CRN’s 100 Coolest Cloud Computing Companies of 2026, here’s a look at 20 innovative software companies that are ...

Companies investing in unified, managed and rich data layers will drive innovation in the coming decade. Through these ...

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Approximately $44 million and $125 million in preliminary (unaudited) Revuforj® (revumenib) 4Q25 and full year 2025 net revenue, respectively - ...

A new University of Helsinki study shows that exposure to indoor air pollution from solid fuels during childhood may have lasting effects on cognitive health, with impairments becoming evident decades ...

The transformation of financial ecosystems to more digital ones is leading to very practical changes in the methods of credit ...

Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and ...

To address this challenge, I propose the 5‑Layer Modernization Stack, a practical, implementation‑ready architecture designed specifically for financial institutions adopting generative AI. This ...

Key data and analytics trends in 2026 include decision intelligence, real-time analytics, semantic layers, platform ...

The next era of fintech leadership will likely be defined not by user interface improvements but by data infrastructure.

IDOR-1117-2520 is now in a Phase 2 proof-of-concept trial in psoriasis, with the potential to expand into additional autoimmune conditions where the CCR6-CCL20 pathway plays a pathogenic role.